Anne Messer - Publications

Neuropharmacology and Neuroscience Albany Medical College of Union University 
Neuroscience Biology, Neurobiology Biology

93 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Messer A, Butler DC. Optimizing intracellular antibodies (intrabodies/nanobodies) to treat neurodegenerative disorders. Neurobiology of Disease. 104619. PMID 31669671 DOI: 10.1016/j.nbd.2019.104619  0.44
2018 Mahajan SP, Meksiriporn B, Waraho-Zhmayev D, Weyant KB, Kocer I, Butler DC, Messer A, Escobedo FA, DeLisa MP. Computational affinity maturation of camelid single-domain intrabodies against the nonamyloid component of alpha-synuclein. Scientific Reports. 8: 17611. PMID 30514850 DOI: 10.1038/s41598-018-35464-7  0.44
2018 Chatterjee D, Bhatt M, Butler D, De Genst E, Dobson CM, Messer A, Kordower JH. Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson's disease model. Npj Parkinson's Disease. 4: 25. PMID 30155513 DOI: 10.1038/s41531-018-0062-4  0.44
2016 Butler DC, Joshi SN, Genst E, Baghel AS, Dobson CM, Messer A. Bifunctional Anti-Non-Amyloid Component α-Synuclein Nanobodies Are Protective In Situ. Plos One. 11: e0165964. PMID 27824888 DOI: 10.1371/journal.pone.0165964  0.92
2015 Ramsingh AI, Manley K, Rong Y, Reilly A, Messer A. Transcriptional dysregulation of inflammatory/immune pathways after active vaccination against Huntington's disease. Human Molecular Genetics. 24: 6186-97. PMID 26307082 DOI: 10.1093/hmg/ddv335  0.92
2015 De Genst E, Chirgadze DY, Klein FA, Butler DC, Matak-Vinković D, Trottier Y, Huston JS, Messer A, Dobson CM. Structure of a single-chain Fv bound to the 17 N-terminal residues of huntingtin provides insights into pathogenic amyloid formation and suppression. Journal of Molecular Biology. 427: 2166-78. PMID 25861763 DOI: 10.1016/j.jmb.2015.03.021  0.44
2014 De Genst E, Messer A, Dobson CM. Antibodies and protein misfolding: From structural research tools to therapeutic strategies Biochimica Et Biophysica Acta - Proteins and Proteomics. 1844: 1907-1919. DOI: 10.1016/j.bbapap.2014.08.016  0.92
2014 Messer A, Manley K, Lemere CA. Immunotherapeutics for Neurological Disorders Handbook of Therapeutic Antibodies: Second Edition. 2: 1215-1230. DOI: 10.1002/9783527682423.ch40  0.92
2013 Bhatt MA, Messer A, Kordower JH. Can intrabodies serve as neuroprotective therapies for Parkinson's disease? Beginning thoughts. Journal of Parkinson's Disease. 3: 581-91. PMID 24270241 DOI: 10.3233/JPD-130252  0.92
2013 Messer A, Joshi SN. Intrabodies as neuroprotective therapeutics. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 10: 447-58. PMID 23649691 DOI: 10.1007/s13311-013-0193-6  0.92
2013 Tomé S, Manley K, Simard JP, Clark GW, Slean MM, Swami M, Shelbourne PF, Tillier ER, Monckton DG, Messer A, Pearson CE. MSH3 polymorphisms and protein levels affect CAG repeat instability in Huntington's disease mice. Plos Genetics. 9: e1003280. PMID 23468640 DOI: 10.1371/journal.pgen.1003280  0.92
2012 Joshi SN, Butler DC, Messer A. Fusion to a highly charged proteasomal retargeting sequence increases soluble cytoplasmic expression and efficacy of diverse anti-synuclein intrabodies. Mabs. 4: 686-93. PMID 22929188 DOI: 10.4161/mabs.21696  0.92
2012 Butler DC, McLear JA, Messer A. Engineered antibody therapies to counteract mutant huntingtin and related toxic intracellular proteins. Progress in Neurobiology. 97: 190-204. PMID 22120646 DOI: 10.1016/j.pneurobio.2011.11.004  0.92
2011 Butler DC, Messer A. Bifunctional anti-huntingtin proteasome-directed intrabodies mediate efficient degradation of mutant huntingtin exon 1 protein fragments. Plos One. 6: e29199. PMID 22216210 DOI: 10.1371/journal.pone.0029199  0.92
2011 Hathorn T, Snyder-Keller A, Messer A. Nicotinamide improves motor deficits and upregulates PGC-1α and BDNF gene expression in a mouse model of Huntington's disease. Neurobiology of Disease. 41: 43-50. PMID 20736066 DOI: 10.1016/j.nbd.2010.08.017  0.92
2010 Snyder-Keller A, McLear JA, Hathorn T, Messer A. Early or late-stage anti-N-terminal Huntingtin intrabody gene therapy reduces pathological features in B6.HDR6/1 mice. Journal of Neuropathology and Experimental Neurology. 69: 1078-85. PMID 20838238 DOI: 10.1097/NEN.0b013e3181f530ec  0.92
2010 Kvam E, Sierks MR, Shoemaker CB, Messer A. Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasm. Protein Engineering, Design & Selection : Peds. 23: 489-98. PMID 20378699 DOI: 10.1093/protein/gzq022  0.92
2010 Messer A. Mini-review: polybrominated diphenyl ether (PBDE) flame retardants as potential autism risk factors. Physiology & Behavior. 100: 245-9. PMID 20100501 DOI: 10.1016/j.physbeh.2010.01.011  0.92
2009 Messer A, Lynch SM, Butler DC. Developing intrabodies for the therapeutic suppression of neurodegenerative pathology. Expert Opinion On Biological Therapy. 9: 1189-97. PMID 19653865 DOI: 10.1517/14712590903176387  0.92
2009 Kvam E, Nannenga BL, Wang MS, Jia Z, Sierks MR, Messer A. Conformational targeting of fibrillar polyglutamine proteins in live cells escalates aggregation and cytotoxicity. Plos One. 4: e5727. PMID 19492089 DOI: 10.1371/journal.pone.0005727  0.92
2008 Lynch SM, Zhou C, Messer A. An scFv intrabody against the nonamyloid component of alpha-synuclein reduces intracellular aggregation and toxicity. Journal of Molecular Biology. 377: 136-47. PMID 18237741 DOI: 10.1016/j.jmb.2007.11.096  0.92
2008 McLear JA, Lebrecht D, Messer A, Wolfgang WJ. Combinational approach of intrabody with enhanced Hsp70 expression addresses multiple pathologies in a fly model of Huntington's disease. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 2003-11. PMID 18199697 DOI: 10.1096/fj.07-099689  0.92
2007 Goryunov D, Adebola A, Jefferson JJ, Leung CL, Messer A, Liem RK. Molecular characterization of the genetic lesion in Dystonia musculorum (dt-Alb) mice. Brain Research. 1140: 179-87. PMID 16725123 DOI: 10.1016/j.brainres.2006.04.068  0.92
2006 Messer A, McLear J. The therapeutic potential of intrabodies in neurologic disorders: focus on Huntington and Parkinson diseases. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. 20: 327-33. PMID 17176119  0.92
2006 Miller TW, Messer A. Gene Therapy for CNS Diseases Using Intrabodies Gene Therapy of the Central Nervous System: From Bench to Bedside. 133-149. DOI: 10.1016/B978-012397632-1/50012-5  0.92
2005 Wolfgang WJ, Miller TW, Webster JM, Huston JS, Thompson LM, Marsh JL, Messer A. Suppression of Huntington's disease pathology in Drosophila by human single-chain Fv antibodies. Proceedings of the National Academy of Sciences of the United States of America. 102: 11563-8. PMID 16061794 DOI: 10.1073/pnas.0505321102  0.92
2005 Miller TW, Messer A. Intrabody applications in neurological disorders: progress and future prospects. Molecular Therapy : the Journal of the American Society of Gene Therapy. 12: 394-401. PMID 15964243 DOI: 10.1016/j.ymthe.2005.04.003  0.92
2005 Miller TW, Zhou C, Gines S, MacDonald ME, Mazarakis ND, Bates GP, Huston JS, Messer A. A human single-chain Fv intrabody preferentially targets amino-terminal Huntingtin's fragments in striatal models of Huntington's disease. Neurobiology of Disease. 19: 47-56. PMID 15837560 DOI: 10.1016/j.nbd.2004.11.003  0.92
2004 Colby DW, Chu Y, Cassady JP, Duennwald M, Zazulak H, Webster JM, Messer A, Lindquist S, Ingram VM, Wittrup KD. Potent inhibition of huntingtin aggregation and cytotoxicity by a disulfide bond-free single-domain intracellular antibody. Proceedings of the National Academy of Sciences of the United States of America. 101: 17616-21. PMID 15598740 DOI: 10.1073/pnas.0408134101  0.92
2004 Zhou C, Emadi S, Sierks MR, Messer A. A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed alpha-synuclein. Molecular Therapy : the Journal of the American Society of Gene Therapy. 10: 1023-31. PMID 15564134 DOI: 10.1016/j.ymthe.2004.08.019  0.92
2004 Shirley LT, Messer A. Early postnatal Purkinje cells from staggerer mice undergo aberrant development in vitro with characteristic morphologic and gene expression abnormalities. Brain Research. Developmental Brain Research. 152: 153-7. PMID 15351503 DOI: 10.1016/j.devbrainres.2004.06.010  0.92
2004 Colby DW, Garg P, Holden T, Chao G, Webster JM, Messer A, Ingram VM, Wittrup KD. Development of a human light chain variable domain (V(L)) intracellular antibody specific for the amino terminus of huntingtin via yeast surface display. Journal of Molecular Biology. 342: 901-12. PMID 15342245 DOI: 10.1016/j.jmb.2004.07.054  0.92
2004 Bolivar VJ, Manley K, Messer A. Early exploratory behavior abnormalities in R6/1 Huntington's disease transgenic mice. Brain Research. 1005: 29-35. PMID 15044061 DOI: 10.1016/j.brainres.2004.01.021  0.92
2004 Emadi S, Liu R, Yuan B, Schulz P, McAllister C, Lyubchenko Y, Messer A, Sierks MR. Inhibiting aggregation of alpha-synuclein with human single chain antibody fragments. Biochemistry. 43: 2871-8. PMID 15005622 DOI: 10.1021/bi036281f  0.92
2004 Murphy RC, Messer A. A single-chain Fv intrabody provides functional protection against the effects of mutant protein in an organotypic slice culture model of Huntington's disease. Brain Research. Molecular Brain Research. 121: 141-5. PMID 14969746 DOI: 10.1016/j.molbrainres.2003.11.011  0.92
2003 Bolivar VJ, Manley K, Messer A. Exploratory activity and fear conditioning abnormalities develop early in R6/2 Huntington's disease transgenic mice. Behavioral Neuroscience. 117: 1233-42. PMID 14674843 DOI: 10.1037/0735-7044.117.6.1233  0.92
2002 Bolivar VJ, Scott Ganus J, Messer A. The development of behavioral abnormalities in the motor neuron degeneration (mnd) mouse. Brain Research. 937: 74-82. PMID 12020865 DOI: 10.1016/S0006-8993(02)02470-8  0.92
2001 Chu-LaGraff Q, Kang X, Messer A. Expression of the Huntington's disease transgene in neural stem cell cultures from R6/2 transgenic mice. Brain Research Bulletin. 56: 307-12. PMID 11719265 DOI: 10.1016/S0361-9230(01)00598-6  0.92
2001 Murphy RC, Messer A. Gene transfer methods for CNS organotypic cultures: A comparison of three nonviral methods Molecular Therapy. 3: 113-121. PMID 11162318 DOI: 10.1006/mthe.2000.0235  0.92
2000 Messer A, Kang X. Control of transcription in the RORa-staggerer mutant mouse cerebellum: Glutamate receptor delta2 mRNA International Journal of Developmental Neuroscience. 18: 663-668. PMID 10978844 DOI: 10.1016/S0736-5748(00)00038-1  0.92
1999 Manley K, Shirley TL, Flaherty L, Messer A. Msh2 deficiency prevents in vivo somatic instability of the CAG repeat in Huntington disease transgenic mice. Nature Genetics. 23: 471-3. PMID 10581038 DOI: 10.1038/70598  0.92
1999 Manley K, Pugh J, Messer A. Instability of the CAG repeat in immortalized fibroblast cell cultures from Huntington's disease transgenic mice Brain Research. 835: 74-79. PMID 10448198 DOI: 10.1016/S0006-8993(99)01451-1  0.92
1999 Messer A, Manley K, Plummer JA. An early-onset congenic strain of the motor neuron degeneration (rand) mouse Molecular Genetics and Metabolism. 66: 393-397. PMID 10191135 DOI: 10.1006/mgme.1999.2817  0.92
1999 Cooper JD, Messer A, Feng AK, Chua-Couzens J, Mobley WC. Apparent loss and hypertrophy of interneurons in a mouse model of neuronal ceroid lipofuscinosis: evidence for partial response to insulin-like growth factor-1 treatment. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 2556-67. PMID 10087069  0.92
1998 Li J, Nixon R, Messer A, Berman S, Bursztajn S. Altered gene expression for calpain/calpastatin system in motor neuron degeneration (Mnd) mutant mouse brain and spinal cord Molecular Brain Research. 53: 174-186. PMID 9473662 DOI: 10.1016/S0169-328X(97)00295-7  0.92
1997 Porter JC, Messer A, Peterson A. The motor neuron degeneration (mnd) gene acts intrinsically in motor neurons and peripheral fibroblasts Molecular and Cellular Neurosciences. 9: 185-193. PMID 9245501 DOI: 10.1006/mcne.1997.0617  0.92
1996 Frantz GD, Wuenschell CW, Messer A, Tobin AJ. Presence of calbindin D28K and GAD67 mRNAs in both orthotopic and ectopic Purkinje cells of staggerer mice suggests that staggerer acts after the onset of cytodifferentiation. Journal of Neuroscience Research. 44: 255-62. PMID 8723764 DOI: 10.1002/(SICI)1097-4547(19960501)44:3<255::AID-JNR6>3.0.CO;2-F  0.92
1996 Porter JC, Messer A. Genetic mapping of farnesyltransferase alpha(Fnta) to mouse Chromosome 8 Mammalian Genome. 7: 622. PMID 8678990  0.92
1995 Plummer J, Peterson A, Messer A. Accelerated and widespread neuronal loss occurs in motor neuron degeneration (mnd) mice expressing a neurofilament-disrupting transgene Molecular and Cellular Neurosciences. 6: 532-543. PMID 8742270 DOI: 10.1006/mcne.1995.0005  0.92
1995 Messer A, Plummer J, MacMillen MC, Frankel WN. Genetics of primary and timing effects in the mnd mouse American Journal of Medical Genetics. 57: 361-364. PMID 7668363 DOI: 10.1002/ajmg.1320570251  0.92
1994 Messer A. Mutant mouse models of ALS Neurobiology of Aging. 15: 247-248. PMID 7838302 DOI: 10.1016/0197-4580(94)90123-6  0.92
1993 Mazurkiewicz JE, Callahan LM, Swash M, Martin JE, Messer A. Cytoplasmic inclusions in spinal neurons of the motor neuron degeneration (Mnd) mouse. I. Light microscopic analysis. Journal of the Neurological Sciences. 116: 59-66. PMID 8389815 DOI: 10.1016/0022-510X(93)90090-L  0.92
1993 Messer A, Plummer J. Accumulating autofluorescent material as a marker for early changes in the spinal cord of the Mnd mouse Neuromuscular Disorders. 3: 129-134. PMID 8358238 DOI: 10.1016/0960-8966(93)90004-4  0.92
1993 Messer A, Plummer J, Wong V, Lavail MM. Retinal degeneration in motor neuron degeneration (mnd) mutant mice. Experimental Eye Research. 57: 637-41. PMID 8282051 DOI: 10.1006/exer.1993.1169  0.92
1993 Battaglioli G, Martin DL, Plummer J, Messer A. Synaptosomal glutamate uptake declines progressively in the spinal cord of a mutant mouse with motor neuron disease. Journal of Neurochemistry. 60: 1567-9. PMID 8095977  0.92
1992 Messer A, Plummer J, Maskin P, Coffin JM, Frankel WN. Mapping of the motor neuron degeneration (Mnd) gene, a mouse model of amyotrophic lateral sclerosis (ALS) Genomics. 13: 797-802. PMID 1639406 DOI: 10.1016/0888-7543(92)90155-L  0.92
1992 Flaherty L, Messer A, Russell LB, Rinchik EM. Chlorambucil-induced mutations in mice recovered in homozygotes. Proceedings of the National Academy of Sciences of the United States of America. 89: 2859-63. PMID 1557392  0.92
1991 Callahan LM, Wylen EL, Messer A, Mazurkiewicz JE. Neurofilament distribution is altered in the Mnd (motor neuron degeneration) mouse. Journal of Neuropathology and Experimental Neurology. 50: 491-504. PMID 2061715  0.92
1991 Messer A, Eisenberg B, Plummer J. The Lurcher cerebellar mutant phenotype is not expressed on a staggerer mutant background Journal of Neuroscience. 11: 2295-2302. PMID 1869916  0.92
1990 Messer A, Plummer-Siegard J, Eisenberg B. Staggerer mutant mouse Purkinje cells do not contain detectable calmodulin mRNA Journal of Neurochemistry. 55: 293-302. PMID 2355223 DOI: 10.1111/j.1471-4159.1990.tb08851.x  0.92
1990 Wuenschell CW, Messer A, Tobin AJ. Lurcher Purkinje cells express glutamic acid decarboxylase and calbindin mRNAs. Journal of Neuroscience Research. 27: 65-70. PMID 2254957 DOI: 10.1002/jnr.490270110  0.92
1989 Messer A, Eisenberg B, Martin DL. Effects of mild hyperthyroidism on levels of amino acids in the developing lurcher cerebellum Journal of Neurogenetics. 5: 77-85. PMID 2703942 DOI: 10.3109/01677068909167266  0.92
1989 Eisenberg B, Messer A. Tonic/clonic seizures in a mouse mutant carrying the weaver gene Neuroscience Letters. 96: 168-172. PMID 2494610 DOI: 10.1016/0304-3940(89)90052-9  0.92
1988 Messer A. Thyroxine injections do not cause premature induction of thymidine kinase in sg/sg mice Journal of Neurochemistry. 51: 888-891. PMID 3411329  0.92
1987 White WF, Regan LJ, Roe AW, Messer A. Behavior, genetics and biochemistry of an allele of the mutant mouse spastic, spaAlb. Journal of Neurogenetics. 4: 253-8. PMID 3668730 DOI: 10.3109/01677068709102345  0.92
1987 Messer A, Strominger NL, Mazurkiewicz JE. Histopathology of the late-onset motor neuron degeneration (mnd) mutant in the mouse Journal of Neurogenetics. 4: 201-213. PMID 3612378 DOI: 10.3109/01677068709102341  0.92
1987 Brugge JS, Lustig A, Messer A. Changes in the pattern of expression of pp60(c-src) in cerebellar mutants of mice Journal of Neuroscience Research. 18: 532-538. PMID 3125343  0.92
1986 Messer A, Flaherty L. Autosomal dominance in a late-onset motor neuron disease in the mouse. Journal of Neurogenetics. 3: 345-55. PMID 3783318 DOI: 10.3109/01677068609106858  0.92
1985 Messer A, Snodgrass GL, Maskin P. Timecourse of effects of triiodothyronine on mouse cerebellar cells cultured by two different methods International Journal of Developmental Neuroscience. 3: 291-299. DOI: 10.1016/0736-5748(85)90034-6  0.92
1984 Messer A, Hatch K. Persistence of cerebellar thymidine kinase in staggerer and hypothyroid mutants Journal of Neurogenetics. 1: 239-248. PMID 6536728 DOI: 10.3109/01677068409107089  0.92
1984 Messer A, Snodgrass GL, Maskin P. Enhanced survival of cultured cerebellar Purkinje cells by plating on antibody to Thy-1 Cellular and Molecular Neurobiology. 4: 285-290. PMID 6395956 DOI: 10.1007/BF00733591  0.92
1984 Messer A, Maskin P, Snodgrass GL. Effects of triiodothyronine (T3) on the development of rat cerebellar cells in culture International Journal of Developmental Neuroscience. 2. DOI: 10.1016/0736-5748(84)90022-4  0.92
1983 Messer A, Jennings R, Maskin P. Low concentrations of trifluoperazine affect striatal cells in culture Journal of Neurochemistry. 41: 903-908. PMID 6619857  0.92
1983 Stanley E, Messer A, Strominger NL. Effects of age and strain differences on the red nucleus of the mouse mutant Dystonia musculorum Anatomical Record. 206: 313-318. PMID 6614514  0.92
1983 Mazurkiewicz JE, Messer A. Simultaneous determination of leu-enkephalin localization and [3H]γ-aminobutyric acid uptake in rat striatal cell cultures Cellular and Molecular Neurobiology. 3: 255-262. PMID 6367989 DOI: 10.1007/BF00710951  0.92
1982 Messer A. Amino Acid Changes in the Mouse Mutant Dystonia Musculorum Similar to Those in Friedreich’s Ataxia Canadian Journal of Neurological Sciences / Journal Canadien Des Sciences Neurologiques. 9: 185-188. PMID 6125255 DOI: 10.1017/S0317167100043936  0.92
1981 Messer A, Mazurkiewicz JE, Maskin P. Growth of dissociated rat cerebellar cells using serum-free supplemented media and varied transferrin concentrations Cellular and Molecular Neurobiology. 1: 99-114. PMID 7346166 DOI: 10.1007/BF00736042  0.92
1981 Messer A, Savage M, Carter TP. Thymidine kinase activity is reduced in the developing staggerer cerebellum Journal of Neurochemistry. 37: 1610-1612. PMID 7334381  0.92
1981 Messer A. Primary monolayer cultures of the rat corpus striatum: Morphology and properties related to acetylcholine and γ-aminobutyrate Neuroscience. 6: 2677-2687. PMID 7322357 DOI: 10.1016/0306-4522(81)90112-3  0.92
1981 Riker DK, Messer A, Roth RH. Increased noradrenergic metabolism in the cerebellum of the mouse mutant dystonia musculorum. Journal of Neurochemistry. 37: 649-54. PMID 6115889  0.92
1980 Messer A, Strominger NL. An allele of the mouse mutant dystonia musculorum exhibits lesions in red nucleus and striatum Neuroscience. 5: 543-549. PMID 7374955 DOI: 10.1016/0306-4522(80)90051-2  0.92
1980 Messer A, Maskin P, Mazurkiewicz JE. Effects of using a chemically defined medium for primary rat monolayer cerebellar cultures: Morphology, GABA uptake and kainic acid sensitivity Brain Research. 184: 243-247. PMID 7357424 DOI: 10.1016/0006-8993(80)90607-1  0.92
1980 Messer A, Maskin P. Short-term effects of kainic acid on rat cerebellar cells in monolayer cultures Neuroscience Letters. 19: 173-177. PMID 7052526 DOI: 10.1016/0304-3940(80)90190-1  0.92
1980 Vaccaro DE, Leeman SE, Messer A, Dichter MA. Primary cultures of dispersed hypothalamic cells from fetal rats: morphology, electrical activity, and peptide content. Journal of Neurobiology. 11: 417-24. PMID 6157000 DOI: 10.1002/neu.480110408  0.92
1980 Messer A. Changes in striatal GABA transport in a neurological mouse mutant Journal of Supramolecular and Cellular Biochemistry. 12.  0.92
1979 Messer A, Gordon D. Changes in whole tissue biosynthesis of γ-amino butyric acid (GABA) in basal ganglia of the dystonia (dtAlb) mouse Life Sciences. 25: 2217-2221. PMID 542100 DOI: 10.1016/0024-3205(79)90095-X  0.92
1978 Hatten ME, Messer A. Postnatal cerebellar cells from staggerer mutant mice express embryonic cell surface characteristic [19] Nature. 276: 504-506. PMID 723931 DOI: 10.1038/276504a0  0.92
1978 Messer A. Abnormal staggerer cerebellar cell interactions and survival in vitro Neuroscience Letters. 9: 185-188. DOI: 10.1016/0304-3940(78)90069-1  0.92
1977 Messer A. Factors influencing monolayer cell culture morphology and survival of cerebellar granule cells from wild-type and mutant mice Progress in Clinical and Biological Research. 15: 251-257. PMID 928455  0.92
1977 Messer A, Smith DM. In vitro behavior of granule cells from staggerer and weaver mutants of mice Brain Research. 130: 13-23. PMID 328112 DOI: 10.1016/0006-8993(77)90839-3  0.92
1977 Messer A. The maintenance and identification of mouse cerebellar granule cells in monolayer culture Brain Research. 130: 1-12. PMID 328111 DOI: 10.1016/0006-8993(77)90838-1  0.92
1977 Messer A, Smith D. Monolayer cultures of mouse cerebellar cells Tissue Culture Association Manual. 3: 691-693. DOI: 10.1007/BF00920383  0.92
1977 Vaccaro D, Messer A. Preparation of fetal rat hypothalmic cells in primary monolayer culture Tissue Culture Association Manual. 3: 561-563. DOI: 10.1007/BF00918381  0.92
Show low-probability matches.